About Linda T. Sánchez
Linda T. Sánchez is a Democratic U.S. Representative from California. She serves in the House of Representatives during the 2025–2027 term and sits on the House Committee on Ways and Means, including its Trade and Health subcommittees. Born January 28, 1969, she represents a district in Southern California and focuses on tax, trade, and health policy through her committee work.
Linda T. Sánchez has disclosed 14 stock trades with an estimated total trading volume of about $0.1 million. Her trading activity is limited compared with many members of Congress and is evenly split between 7 buys and 7 sells. The most frequently traded stocks in her disclosures are Walt Disney (DIS), Ford (F), UBS Group (UBS), and Pfizer (PFE), each appearing in two transactions, followed by Cisco Systems (CSCO) with one. The small number of trades and balanced buy-sell ratio indicate relatively modest and infrequent trading activity.
Linda T. Sánchez's Trades
Trading Activity
| Date | Asset | Type | Amount |
|---|---|---|---|
| 2025-10-28 | CSCO | sell | $1K-$15K |
| 2019-02-22 | UBSOTHE | sell | $1K-$15K |
| 2019-02-22 | RTNBOTHE | sell | $25+ |
| 2019-02-22 | FOTHE | sell | $1K-$15K |
| 2019-02-22 | ENBOTHE | sell | $1K-$15K |
| 2019-02-22 | BACOTHE | sell | $1K-$15K |
| 2017-08-04 | DIS | sell | $1K-$15K |
| 2017-08-04 | PFE | sell | $1K-$15K |
| 2017-08-04 | MSFT | sell | $1K-$15K |
| 2017-05-17 | F | buy | $1K-$15K |
| 2016-08-09 | DIS | sell | $1K-$15K |
| 2016-08-09 | PFE | sell | $1K-$15K |
| 2016-08-09 | INTC | sell | $1K-$15K |
| 2016-07-05 | UBS | buy | $1K-$15K |
| 2016-01-19 | UBS | buy | $1K-$15K |
| 2016-01-19 | SE | buy | $1K-$15K |
| 2016-01-19 | F | buy | $1K-$15K |
| 2016-01-19 | BAC | buy | $1K-$15K |
| 2015-04-21 | RTNB | buy | $1K-$15K |
| 2005-06-10 | Real property, 305 C St., N.E., #105, Washington, DCOTHE | sell | $250K-$500K |
Estimated current holdings
Derived from disclosed buys minus sells at range midpoints. Positions opened before disclosure records began, or reported only in ranges, make this an estimate of direction and scale, not a brokerage statement.